GxPinnacle Logo

Pharmacovigilance Regulatory Expectations

What Do Inspectors Check for Pharmacovigilance KPI Design and Metric Selection?

Regulators expect pharmacovigilance systems to define meaningful performance indicators that monitor compliance, safety processes, and operational performance. KPI design should include structural, process, and outcome metrics aligned with regulatory obligations and PV system governance.

Founders, CEOs & MDsPV LeadsQA/ComplianceScientists tasked with documentation

The short version

What teams need to understand

  • Pharmacovigilance systems should define KPIs that monitor operational performance and regulatory compliance.
  • KPI frameworks should include structural, process, and outcome indicators.
  • Metrics should be aligned with key PV processes including ICSR management, aggregate reporting, signal management, and quality system oversight.
  • KPI targets and thresholds should be defined to identify performance deviations.
  • Performance indicators should support early detection of operational or compliance risks.
  • Inspection-ready evidence should demonstrate that KPIs are defined, monitored, and linked to governance oversight.

Regulatory expectation

What regulators expect

Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.

  • PV systems must define measurable indicators that monitor compliance and operational performance.
  • KPI frameworks must cover key pharmacovigilance processes.
  • Metrics must have defined targets and escalation thresholds.
  • KPI definitions must be documented and consistently interpreted.
  • KPIs must support governance oversight and continuous improvement.

Why it matters

What this means in practice

Inspectors assess whether pharmacovigilance systems define meaningful KPIs that monitor safety performance, regulatory compliance, and operational effectiveness. They typically review KPI definitions, target thresholds, metric coverage across PV activities, and evidence that indicators support oversight and continuous improvement.

Questions this page answers

What pharmacovigilance KPIs should be monitored?
Examples of pharmacovigilance KPIs inspectors expect
How should PV performance metrics be designed?
What metrics demonstrate pharmacovigilance system performance?
What KPIs should QPPVs monitor?
How do inspectors evaluate PV metrics frameworks?
What pharmacovigilance performance indicators are used in practice?
How should KPI thresholds be defined in pharmacovigilance?
What evidence demonstrates KPI design during inspections?
What are common PV KPI examples used by safety teams?

Inspection evidence

Evidence teams should be able to show

KPI Definition Framework

  • Documented list of PV KPIs
  • Categorisation of structural, process, and outcome metrics
  • Defined KPI owners and responsible functions
  • Defined targets and thresholds for each metric
  • Documented rationale for KPI selection

PV KPI Master Tracker

  • Centralised list of all PV KPIs
  • Assigned KPI owners
  • Data sources used for KPI measurement
  • Defined targets and escalation thresholds
  • Defined reporting cadence

Metric Definitions and Calculation Logic

  • Formal definitions of KPI metrics
  • Calculation formulas used to determine performance values
  • Defined reporting periods for measurement
  • Documentation ensuring consistency of KPI interpretation

Regulatory Basis (Primary Sources)

  • GVP Module I - pharmacovigilance systems must monitor performance and quality
  • GVP Module IV - PV audits and compliance oversight expectations
  • ICH E2D - post-approval safety reporting principles supporting PV system monitoring
  • ICH E2E - pharmacovigilance planning guidance supporting safety system performance monitoring
  • MHRA Good Pharmacovigilance Practice (GPvP) guidance - expectations for PV system governance and oversight
  • FDA pharmacovigilance guidance - expectations for monitoring safety system performance and regulatory compliance

Typical Inspection Questions (What Inspectors Ask)

  • What KPIs do you use to monitor pharmacovigilance performance?
  • How were your KPIs selected and defined?
  • How do you ensure KPIs cover all critical PV processes?
  • Show me the definitions and calculation logic for your PV KPIs.
  • How do you determine KPI thresholds and escalation triggers?

Common failure patterns

KPIs are defined but do not cover all key pharmacovigilance processes.
Metrics exist but definitions or calculation logic are unclear.
Targets and thresholds are not defined or not aligned with regulatory expectations.
KPIs focus only on operational metrics without measuring compliance risks.
KPI definitions vary across teams leading to inconsistent reporting.

What good looks like

  • A structured KPI framework covering structural, process, and outcome indicators.
  • Metrics aligned with key pharmacovigilance activities such as case management, signals, reporting, and quality oversight.
  • Clear definitions and calculation logic for each KPI.
  • Defined targets and thresholds enabling early detection of performance issues.
  • KPI design supporting governance oversight and continuous improvement.

How teams operationalise it

  • Define a structured KPI framework covering structural, process, and outcome indicators.
  • Ensure KPIs cover key PV activities including case processing, signal management, reporting, and governance.
  • Document metric definitions and calculation logic to ensure consistency.
  • Define targets and escalation thresholds aligned with regulatory expectations.
  • Ensure KPI results feed into governance review and improvement processes.

From expectation to working control

Find the documentation that supports this work

Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.

Browse pharmacovigilance toolkitsView related toolkit

Frequently asked questions

What are examples of pharmacovigilance KPIs?

Common examples include ICSR reporting timeliness, case quality scores, signal evaluation timelines, PSUR submission compliance, CAPA closure rates, and training completion metrics.

Why do pharmacovigilance systems use KPIs?

KPIs allow organisations to measure PV system performance, detect compliance risks early, and ensure safety processes operate effectively.

What types of KPIs should a PV system include?

PV KPI frameworks typically include structural indicators (system infrastructure), process indicators (execution of PV activities), and outcome indicators (overall compliance and safety performance).

How are pharmacovigilance KPI targets defined?

Targets are typically aligned with regulatory requirements, industry benchmarks, and internal performance expectations.

Do inspectors review pharmacovigilance KPIs during inspections?

Yes. Inspectors frequently request KPI frameworks and dashboards to confirm that PV systems actively monitor performance and compliance.

How do inspectors verify KPI design during PV inspections?

Inspectors typically review KPI definitions, performance thresholds, and governance records to confirm that metrics are meaningful and aligned with PV system oversight.

Source boundary

Regulatory sources

These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.

European Medicines Agency (EMA)

  • Good pharmacovigilance practices (GVP)

    View source

  • Guideline on good pharmacovigilance practices (GVP) - Module I

    View source

International Council for Harmonisation (ICH)

  • Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting (E2D)

    View source

  • Pharmacovigilance Planning (E2E)

    View source

U.S. Food and Drug Administration (FDA)

  • Postmarketing Safety Reporting for Human Drug and Biological Products

    View source

UK MHRA (GOV.UK)